Jaime Brozowski, M.S. is a third year Ph.D. Candidate, HHMI Translational Medicine Trainee and Women in Science at UNC Chair.
Business and nursing staff on opening day of the Therapeutic Infusion Center
UNC Hospitals and the Division of Rheumatology, Allergy and Immunology are excited to announce the opening of the UNC Hospitals Therapeutic Infusion Center at Carolina Pointe II!
The new twenty-two seat Infusion Center is located on the second floor of 6013 Farrington Road in Chapel Hill. Here, a skilled team of nurses, led by Lana Amend, RN and Suzanne Francart, PharmD, will perform non-oncologic infusions for patients from numerous specialties including - but not limited to - Rheumatology, Gastroenterology, Neurology, and Benign Hematology. The Infusion Center is led by two clinical faculty of the Division of Rheumatology, Allergy and Immunology and the UNC Thurston Arthritis Research Center; Dr. Alfredo Rivadeneira will serve as Director and Dr. Bill Yount as Associate Director.
If you would like to inquire about utilizing infusion services for your patients – please contact Alex Nance at Alexander.Nance@unchealth.unc.edu
Check out this great article about our center! Drs. Jordan, Tarrant, Callahan, Loeser and Sheikh were all contributors.
Read the full article on the NIH website; http://www.nih.gov/news/health/feb2015/niams-17.htm
UNC TARC's Beth Jonas, MD has been awarded the 2014 Clinician Scholar Educator Award from the American College of Rheumatology. The purpose of the Clinician Scholar Educator Award is to develop and support educators who are dedicated to providing a high-quality clinical educational experience to future rheumatologists and rheumatology health professionals.
As Director for our Rheumatology Fellowship Training Program, she has been intimately involved in the education of our fellows and medical residents and is now playing a vital role in our Division’s involvement in UNC’s current revamping of our medical student curriculum. The implementation of this award will coincide perfectly with the rollout of the new medical school curriculum, Translational Education at Carolina (TEC). As an active member of the Foundation Phase group, she has been a key contributor in helping develop the basic framework for the Multi-Organ Synthesis Course and will be using the CSE award to develop a spaced learning component in an integrated rheumatology curriculum.
There is a paucity of rheumatology content in our current curriculum at UNC, as in many medical schools. The rollout of our new curriculum provides an outstanding opportunity to enhance rheumatology education for our medical students, with the goal of ultimately directing more students early in their development into rheumatology as a possible career choice.
We could not be more pleased with the College’s selection of Dr. Jonas for this award. Please join us in congratulating Dr. Jonas on receiving this most prestigious recognition.
Dr. Cleveland received her PhD at UNC and completed a postdoctoral fellowship at the International Agency for Research on Cancer. She is a member of the Methodology Core in TARC’s Multidisciplinary Clinical Research Center, TARC’s Epidemiology Strategic Planning Committee and has been a key contributor to study design for grant submissions as well as guiding, performing and interpreting statistical analyses for several ongoing projects. She has given numerous presentations at the American College of Rheumatology’s Annual Scientfic Meeting and the Osteoarthritis Research Society International meeting. She has also been an active mentor for graduate and medical students at TARC. Her research interests span multiple areas including osteoarthritis, rheumatoid arthritis, obesity, physical activity, mortality, biomarkers, diabetes, genetics and social determinants.
Please join us in welcoming Dr. Cleveland to the faculty!
Dr. Matthew Billard has been a postdoctoral fellow at UNC TARC and has now joined our faculty as an Assistant Professor. Dr. Billard's new faculty appointment is in the Department of Medicine as an Assistant Professor. During the past few years as a postdoctoral fellow in our department, he has shown exceptional promise and we are thrilled to welcome him to the faculty.
Dr. Billard completed his undergraduate degree in Biology at the University of Illinois at Urbana-Champaign, his Masters degree in Biology from Illinois State University, and his PhD in Immunology at University of Texas MD Anderson Cancer Center. Following that, he completed a postdoctoral fellowship in the Department of Biostatistics and Bioinformatics at Duke University, combining aspects of statistics, mathematics, computer modeling, and experimental immunology. He was recruited to the UNC TARC laboratory of Dr. Teresa Tarrant as a senior postdoctoral fellow since his research experiences and career interests were germane to Dr. Tarrant’s in chemokine receptor signaling, cell migration, and immunology. Dr. Billard was awarded a K01 career development grant on systems biology of the GPCR ligand-receptor interaction in immune cell migration.
Tune in via podcast at: http://yourhealthradio.org
Listen live on:
WCHL 97.9 FM, Saturday at 9 AM, Sunday at 9 AM & 5 PM and Monday at 6 & 10 PM
This study is examining the near-term effects of the self-directed format of the program on improvements in primary outcomes of pain, stiffness, fatigue; secondary outcomes of self-reported physical and psychosocial functioning, and program satisfaction. Dr. Alfredo Rivadeneira is a Co-Investigator on the project.
To date, Dr. Callahan and her team have recruited 80 participants in CELAH (Center for Latino Health) Clinics at UNC (Rheumatology, Geriatrics, Internal Medicine, Orthopaedics, Gastrointestinal) and at a Health Fair for Latino Women at the St. Thomas More Church. The team plans to include recruitment outreach at Triangle area churches, the Mexican Consulate in Raleigh and Bethesda Health Center in Charlotte. Dr. Callahan was the Principal Investigator for the Arthritis Foundation’s “Evaluation of Walk with Ease in Arthritis” which established the evidence base for the program among people with arthritis.